This activity has been designed to meet the educational needs of clinicians and non-clinicians involved in the care of patients with atopic dermatitis.
- Recognize the impacts of sleep disturbance on patients with moderate to severe atopic dermatitis
- Describe the complex mechanisms of sleep disturbance in atopic dermatitis
- Identify appropriate therapeutic strategies for sleep disturbance in atopic dermatitis
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
The authors reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
|Name of Faculty||Reported Financial Relationship|
|Peter Lio, MD||
Grants/Research Support: Investigator for AbbVie,
Regeneron/Sanofi-Genzyme, and AOBiome.
Consulting Fees: Johnson & Johnson, IntraDerm,
Regeneron/Sanofi-Genzyme, Exeltis, Theraplex, Realm,
Pfizer, L'Oreal, Menlo, AbbVie, Syncere Skin Systems,
Kiniksa, Eli Lilly, DermVeda, Unilever, UCB Altus,
Dermavant, Dermira, Micreos, LearnSkin, Verrica,
TopMD, Amyris, LEO, Arbonne, Burt's Bees, National Eczema Association.
Speakers Bureau: Pfizer, Regeneron/Sanofi-Genzyme, L'Oreal.
Ownership Interest/Stock Holder: Syncere Skin Systems, DermVeda, Altus Labs, Micreos, LearnSkin. Royalty: Theraplex.
The content managers reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity:
|Name of Content Manager||Reported Financial Relationship|
|Venita Sivamani, Planner||LearnHealth founder and shareholder|
|Planners at Medical Education Resources||No financial relationships to disclose|
|In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and LearnHealth. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
Medical Education Resources designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical Education Resources designates this live activity for a maximum of 0.5 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Method of Participation
There are no fees for participating in and receiving credit for this activity. During July 14, 2021 through June 9, 2024, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Statements of credit will be issued.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, LearnHealth, and/or Pfizer. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Medical Education Resources and LearnHealth maintain high standards for the protection of privacy over the Internet. The purpose of this statement is to explain what information we obtain, how it is used, and how visitors can restrict its use or disclosure.
The only information MER obtains is information supplied voluntarily by the visitor.
We do not sell or disclose individually identifiable information obtained online unless it is required by law or disclosure is necessary to protect the safety of customers, employees, or property.
We use the information to grade your posttest and to send you a certificate of completion of the activity. If we use a third-party company to grade your posttest and issue certificates of completion, we will give the information to that company for that purpose only.
For each activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
We may use the information to invite you to participate in other activities that we may offer.
This activity is jointly provided by Medical Education Resources and LearnHealth Inc.
For questions regarding accreditation, please contact MER at email@example.com. For all other questions, please contact firstname.lastname@example.org.